Purchase this article with an account.
R. J. Collier, Jr., Y. Wang, E. Martin, C. Romano; Complement Components in Photic-Induced Retinopathy. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5916. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Increased risk for development of AMD has been associated with modifications in genes associated with the complement system (complement factor H, complement factor B, complement component 2 and HTRA1/LOC387715). The purpose of this study was to evaluate the role of complement activation in light-exposed retinas.
Albino rats were dark adapted for 24 hrs prior to light exposure. Control rats (N=3) remained in the dark while experimental rats (N=3 per group) were exposed to blue light (220 fc) for 6 hours. Retinas were examined after 3 hours of light exposure, immediately following the 6-hour light treatment, or 1, 2 and 7 days after a 6-hour photic insult. Immunohistochemical localization of C3 and C1q was determined in paraffin embedded tissue.
Pyknotic nuclei in the ONL (>50%) were observed in retinas obtained immediately after a 6-hour blue-light exposure which was followed by thinning of the ONL. C1q expression was not observed in control retinas or light-exposed retinas evaluated immediately following light exposure or 1 to 7 days after light exposure. C3 expression was not observed in retinas evaluated immediately after 3 or 6-hour light exposures but was present in retinas examined 1 to 7 days after light exposure. C3 expression was observed in the RPE, subretinal space and ONL.
Blue-light exposure results in activation of the alternative complement pathway (positive C3 expression, negative C1q expression). This model may have utility in evaluating therapeutic agents to treat AMD.
This PDF is available to Subscribers Only